article thumbnail

Phase I trial launches into oral drug for radioactive contamination

Drug Discovery World

A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults.

article thumbnail

Making sub-visible particles visible

Bio Pharma Dive

Sub-visible particles can lower the effectiveness of a drug, which is why regulatory authorities are demanding processes be developed, validated and set up in such a way as to minimize all forms of contamination.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SnoreStop NasoSpray is Voluntarily Recalled by Green Pharmaceuticals Due to Microbial Contamination

XTalks

The US Food and Drug Administration (FDA) found the 0.3 FL OZ (9 mL) nasal spray bottles to be contaminated with the bacteria, Providencia rettgeri. Previous and emerging research on this bacterium has associated it with intrinsic multi-drug resistance and nosocomial infections (also referred to as hospital-acquired infections).

article thumbnail

This week in drug discovery (15-19 May)

Drug Discovery World

In-human studies have been initiated to test treatments for Parkinson’s disease, radioactive contamination, Dravet Syndrome, influenza and inflammatory diseases. The post This week in drug discovery (15-19 May) appeared first on Drug Discovery World (DDW).

article thumbnail

Choosing a Baby Formula

Pharma Mirror

Families are taking a hard look at how baby formulas’ ingredients impact their children’s health and development. In the United States, the Food and Drug Administration (FDA) set out some very broad guidelines concerning nutrients that should be included in baby formula.

article thumbnail

STAT+: Major Indian generic drugmaker closes a U.S. facility after years of manufacturing problems

STAT News

federal court ordered a unit of Wockhardt, one of the largest makers of generic drugs, to refrain from making allegedly adulterated medicines at a facility in Illinois. After a decade of manufacturing problems, a U.S. However, the U.S. Continue to STAT+ to read the full story…

article thumbnail

CMO Moves: Regulatory catalysts for drug manufacturing-April

Pharmaceutical Technology

Regulatory decisions have a ripple effect, first affecting the pharma sponsors, and then the companies tasked to manufacture the drug. Pharmaceutical Technology looks at drugs and biologics with recent regulatory verdicts that will likely impact manufacturing volumes.